-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
$3.5 Million Bet On Aziyo Biologics? Check Out These 3 Penny Stocks Insiders Are Buying
$3.5 Million Bet On Aziyo Biologics? Check Out These 3 Penny Stocks Insiders Are Buying
The Dow Jones closed almost flat on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Aziyo Biologics
- The Trade: Aziyo Biologics, Inc. (NASDAQ:AZYO) Director Kevin Rakin bought a total of 735,000 shares at an average price of $4.75. To acquire these shares, it cost around $3.49 million.
- What's Happening: Aziyo Biologics recently announced pricing of an $11.2 million public offering of common stock.
- What Aziyo Biologics Does: Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.
Genius Brands International
- The Trade: Genius Brands International, Inc. (NASDAQ:GNUS) Director Cynthia Turner-Graham acquired a total of 5,000 shares at an average price of $0.73. The insider spent around $3.67 thousand to buy those shares.
- What's Happening: The company, last month, posted a sharp rise in quarterly sales.
- What Genius Brands International Does: Genius Brands International Inc is a kids media company. It is engaged in developing, producing, marketing, and licensing branded children's entertainment properties and consumer products for media and retail distribution.
Investor Sentiment Drops Further After S&P 500 Falls For Fifth Session
Don't forget to check out our premarket coverage here .
Redwire
- The Trade: Redwire Corporation (NYSE:RDW) Director John Bolton acquired a total of 43,839 shares at an average price of $2.01. To acquire these shares, it cost around $88.12 thousand.
- What's Happening: The company, last month, said revenue increased 14.0% to $37.2 million for the three months ended September 30, 2022.
- What Redwire Does: Redwire Corp is engaged in mission-critical space solutions and reliable components for the next generation space economy, with IP for solar power generation and in-space 3D printing and manufacturing.
The Dow Jones closed almost flat on Wednesday. Investors, meanwhile, focused on some notable insider trades.
道琼斯指数周三收盘几乎持平。同时,投资者将注意力集中在一些值得注意的内幕交易上。
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
当内部人士购买或出售股票时,这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将其视为影响其整体投资或交易决策的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多,请查看 本辛加的内幕交易 平台。
Aziyo Biologics
Azio Biologics
- The Trade: Aziyo Biologics, Inc. (NASDAQ:AZYO) Director Kevin Rakin bought a total of 735,000 shares at an average price of $4.75. To acquire these shares, it cost around $3.49 million.
- What's Happening: Aziyo Biologics recently announced pricing of an $11.2 million public offering of common stock.
- What Aziyo Biologics Does: Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.
- 交易: Aziyo Biologics, Inc. (纳斯达克股票代码:AZYO)导演凯文·拉金 共购买了73.5万股股票 平均价格为4.75美元。收购这些股票的成本约为349万美元。
- 发生了什么: Aziyo Biologics最近宣布了1,120万美元公开发行普通股的定价。
- Aziyo Biologics 的作用: Aziyo Biologics Inc是一家商业阶段的再生医学公司,专注于开发下一代差异化产品并改善接受手术的患者的预后,重点关注接受植入式医疗设备的患者。
Genius Brands International
天才品牌国际
- The Trade: Genius Brands International, Inc. (NASDAQ:GNUS) Director Cynthia Turner-Graham acquired a total of 5,000 shares at an average price of $0.73. The insider spent around $3.67 thousand to buy those shares.
- What's Happening: The company, last month, posted a sharp rise in quarterly sales.
- What Genius Brands International Does: Genius Brands International Inc is a kids media company. It is engaged in developing, producing, marketing, and licensing branded children's entertainment properties and consumer products for media and retail distribution.
- 这笔交易: 天才品牌国际有限公司 (纳斯达克股票代码:GNUS)导演辛西娅·特纳-格雷厄姆 共收购了 5,000 股股票 平均价格为0.73美元。知情人士花了大约3.67万美元购买了这些股票。
- 发生了什么:该公司上个月公布季度销售额急剧增长。
- 天才品牌国际在做什么: Genius Brands国际公司是一家儿童媒体公司。它从事开发、生产、营销和许可品牌儿童娱乐资产和消费品,用于媒体和零售分销。
Investor Sentiment Drops Further After S&P 500 Falls For Fifth Session
标准普尔500指数连续第五个交易日下跌后,投资者情绪进一步下降
Don't forget to check out our premarket coverage here .
别忘了在这里查看我们的上市前报道。
Redwire
Redwire
- The Trade: Redwire Corporation (NYSE:RDW) Director John Bolton acquired a total of 43,839 shares at an average price of $2.01. To acquire these shares, it cost around $88.12 thousand.
- What's Happening: The company, last month, said revenue increased 14.0% to $37.2 million for the three months ended September 30, 2022.
- What Redwire Does: Redwire Corp is engaged in mission-critical space solutions and reliable components for the next generation space economy, with IP for solar power generation and in-space 3D printing and manufacturing.
- 这笔交易: Redwire 公司 (纽约证券交易所代码:RDW)导演约翰·博尔顿 共收购了 43,839 股股票 平均价格为2.01美元。收购这些股票的成本约为88.12万美元。
- 发生了什么:该公司上个月表示,在截至2022年9月30日的三个月中,收入增长了14.0%,达到3,720万美元。
- Redwire 是干什么的: Redwire Corp致力于为下一代太空经济提供关键任务太空解决方案和可靠组件,其知识产权用于太阳能发电和太空3D打印和制造。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧